- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03723434
Physiology of Interregional Connectivity in the Human Brain
Study Overview
Status
Conditions
Detailed Description
This study consists of two experiments.
In Experiment A, healthy participants without disorders or medications influencing brain function (N=24) will be recruited. A range of negative and positive asynchronies (from minus 50 to + 50 ms) will be tested. To allow comparison with prior studies that used MEPs as outcome measures, in 12 participants the primary motor cortex in the left and right hemisphere will be targeted. In another 12 participants, two cortical areas within the same hemisphere will be stimulated.
In Experiment B, participants with stroke, traumatic brain injury (TBI), or multiple sclerosis (MS) (total maximum N across all such participants is 52) will be recruited. These participants are required to have one or more subcortical white matter lesions, which would be expected to result in cortico-cortical disconnections. Here, the investigators will only test PAS with positive asynchronies, with the goal of testing if the findings observed in healthy participants are similar in participants with white matter lesions. It will also be examined if the PAS-induced connectivity changes persist beyond the stimulation sessions if PAS is given repeatedly over several days. PAS will be applied to two cortical targets that have been disconnected from each other. The rationale for including more than one disorder in Experiment B is that the disconnections are in all cases caused by white matter lesions and the results may therefore be similar. To detect possible differences between disorders, the data from the three groups will also be analyzed separately.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tommi Raij, MD, PhD
- Phone Number: 312-238-4401
- Email: tommi.raij@northwestern.edu
Study Contact Backup
- Name: Julio C Hernandez Pavon, PhD, DSc
- Phone Number: 312-238-6820
- Email: julio.hpavon@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Shirley Ryan AbilityLab
-
Contact:
- Tommi Raij, MD, PhD
- Phone Number: 312-238-4401
- Email: tommi.raij@northwestern.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion Criteria for Healthy Participants:
- Age from 18 to 85 years
- Right-handed
- Normal hearing and (corrected) vision
- Able to understand and give informed consent
- English speaker
Inclusion Criteria for Patients:
- Age from 18 to 85 years
- Stroke (ischemic subcortical, intermediate level, chronic phase 3 weeks or more from lesion)
- TBI (closed-skull, intermediate level, chronic phase 3 weeks or more from lesion)
- MS (white matter subcortical lesion)
- Clinical and radiological evidence supporting the above diagnoses
- One or more behavioral symptoms possibly linked to the white matter lesion(s)
- Stable medical condition
- English speaker
Exclusion Criteria:
Exclusion Criteria for Healthy Participants:
- Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
- Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
- Surgical clips in the head or previous neurosurgery
- Any magnetic particles in the body
- Cochlear implants
- Prosthetic heart valves
- Epilepsy or any other type of seizure history
- Any neurological diagnoses or medications influencing brain function
- History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
- Known structural brain lesion
- Significant other disease (heart disease, malignant tumors, mental disorders)
- Significant claustrophobia; Ménière's disease
- Pregnancy (ruled out by urine ß-HCG if answers to screening questions suggest that pregnancy is possible), breast feeding
- Non prescribed drug use
- Failure to perform the behavioral tasks or neuropsychological evaluation tests
- Prisoners
Exclusion Criteria for Patients:
- Same as above, excluding the requirement of no structural brain lesion, and medications influencing brain function are allowed
- Patients with cortical lesions or CSF-filled cysts/cavities near the TMS sites
- MS patients with acute exacerbation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Healthy Participants
Healthy participants without disorders or medications influencing brain function will be scanned with MRI and undergo single-pulse TMS and PAS during several visits, each with a different asynchrony, while EEG and MEPs are recorded.
|
Single-pulse TMS (spTMS) will be delivered with a TMS stimulator (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and a figure-of-eight TMS coil.
80 spTMS will be repeated at 0.2 Hz.
An MRI-based TMS navigation system will be used to navigate the TMS coil (Localite, St Augustin, Germany).
Paired associative stimulation (PAS) will be applied with two TMS stimulators (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and two TMS coils.
The pulses from each stimulator/coil will be repeated at 0.2 Hz, duration of run 15 minutes (180 pulses for each stimulator/coil).
In different sessions, we will deliver PAS with different asynchrony values to examine their effects on effective connectivity.
Coils will be navigated using an MRI-based TMS navigation system (Localite, St Augustin, Germany).
Repetitive TMS (rTMS) will be applied at 1 and 20 Hz with a TMS stimulator (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and a figure-of-eight TMS coil.
300 rTMS pulses will be delivered during 1 and 20 Hz stimulation.
An MRI-based TMS navigation system will be used to navigate the TMS coil (Localite, St Augustin, Germany).
|
Experimental: Patients
Participants with stroke, traumatic brain injury (TBI), or multiple sclerosis (MS) will be scanned with MRI and undergo single-pulse TMS and paired associative stimulation during several visits while EEG is recorded.
|
Single-pulse TMS (spTMS) will be delivered with a TMS stimulator (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and a figure-of-eight TMS coil.
80 spTMS will be repeated at 0.2 Hz.
An MRI-based TMS navigation system will be used to navigate the TMS coil (Localite, St Augustin, Germany).
Paired associative stimulation (PAS) will be applied with two TMS stimulators (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and two TMS coils.
The pulses from each stimulator/coil will be repeated at 0.2 Hz, duration of run 15 minutes (180 pulses for each stimulator/coil).
In different sessions, we will deliver PAS with different asynchrony values to examine their effects on effective connectivity.
Coils will be navigated using an MRI-based TMS navigation system (Localite, St Augustin, Germany).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in EEG effective connectivity
Time Frame: Experiment A: Within-session (before versus after PAS at 1 and 60 minutes). Experiment B: Within-session (before versus after PAS at 1 and 60 minutes). Across-sessions (persistence of changes up to 1 month after last PAS session).
|
EEG will be recorded with a 64-channel whole-head TMS-compatible device (NeurOne, Bittium, Kuopio, Finland).
Data will be collected before (Pre-PAS) and at 1 minute (Post-PAS T1) and at 60 minutes (Post-PAS T60) after PAS.
To record spTMS-evoked EEG responses the investigators will deliver 80 single TMS pulses to the two areas receiving PAS, one target after the other in separate runs.
Effective connectivity will be measured by comparing the source-resolved EEG evoked response waveforms before (Pre-PAS) and at 1 (Post-PAS T1) and at 60 minutes after PAS (Post-PAS T60).
|
Experiment A: Within-session (before versus after PAS at 1 and 60 minutes). Experiment B: Within-session (before versus after PAS at 1 and 60 minutes). Across-sessions (persistence of changes up to 1 month after last PAS session).
|
Changes in resting-state EEG coherence
Time Frame: Experiment A: Within-session (before versus after PAS at 1 and 60 minutes). Experiment B: Within-session (before versus after PAS at 1 and 60 minutes). Across-sessions (persistence of changes up to 1 month after last PAS session).
|
Resting-state EEG will be recorded with a 64-channel whole-head device (NeurOne, Bittium, Kuopio, Finland).
Data will be collected before (Pre-PAS) and at 1 minute (Post-PAS T1) and at 60 minutes (Post-PAS T60) after PAS.
Resting-state EEG coherence will be computed in the source space for the two areas receiving PAS from 1 to 100 Hz.
|
Experiment A: Within-session (before versus after PAS at 1 and 60 minutes). Experiment B: Within-session (before versus after PAS at 1 and 60 minutes). Across-sessions (persistence of changes up to 1 month after last PAS session).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Motor evoked potentials (MEPs)
Time Frame: Experiment A: Within-session (before versus after PAS at 1 and 60 minutes). Experiment B: Done only in patients where the M1 was targeted with PAS.
|
To assess the effects of PAS in participants where the primary motor cortex (M1) was targeted, spTMS will be administered to the M1 at 110% of resting motor threshold (rMT) while MEPs are recorded from the contralateral hand (NeurOne, Bittium, Kuopio, Finland).
The MEPs will be recorded before (Pre-PAS), at 1 minute (Post-PAS T1) and at 60 minutes (Post-PAS T60) after PAS.
|
Experiment A: Within-session (before versus after PAS at 1 and 60 minutes). Experiment B: Done only in patients where the M1 was targeted with PAS.
|
MRI functional connectivity
Time Frame: Experiment A: Baseline. Experiment B: Baseline to 1 month after the last PAS session.
|
Functional connectivity will be assessed with resting-state MRI (rs-MRI).
|
Experiment A: Baseline. Experiment B: Baseline to 1 month after the last PAS session.
|
MRI structural connectivity
Time Frame: Experiment A: Baseline. Experiment B: Baseline to 1 month after the last PAS session.
|
Structural connectivity will be assessed with diffusion tensor imaging (DTI).
|
Experiment A: Baseline. Experiment B: Baseline to 1 month after the last PAS session.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tommi Raij, MD, PhD, Shirley Ryan AbilityLab 355 East Erie St, Chicago, IL Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, IL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Wounds and Injuries
- Craniocerebral Trauma
- Trauma, Nervous System
- Multiple Sclerosis
- Sclerosis
- Brain Injuries
- Brain Injuries, Traumatic
Other Study ID Numbers
- STU00204239
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Single-pulse transcranial magnetic stimulation (spTMS)
-
Massachusetts General HospitalNational Institute of Neurological Disorders and Stroke (NINDS)Not yet recruiting
-
University of MinnesotaCompleted
-
University of MinnesotaNational Institute of Mental Health (NIMH)RecruitingDepression | Suicidal Ideation | Suicidal Behavior | Negative Urgency | Cortical InhibitionUnited States
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedStrokeUnited States
-
University of MichiganMedical University of South Carolina; National Center of Neuromodulation for...RecruitingAnterior Cruciate Ligament InjuryUnited States
-
Massachusetts General HospitalNot yet recruiting
-
University of AarhusUnknownSubarachnoid Hemorrhage | Anoxic Brain Injury | Severe Traumatic Brain InjuryDenmark
-
Medical University of ViennaCampus Bio-Medico UniversityRecruitingFatigue | Post-COVID-19 SyndromeAustria, Italy
-
Western University, CanadaRecruiting
-
University of FloridaRecruiting